🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
July 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — July 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1439)
All (1439)
Buys (155)
Sells (1284)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Azenta, Inc.
(AZTA)
Starr Ephraim
— SVP, Gen Counsel&Secretary
Jul 31, 2026
Purchase
Shares
335
Price
$24.17
Total Value
$8.10K
Shares Held After
68,728
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DAVITA INC.
(DVA)
BERKSHIRE HATHAWAY INC
— 10% Owner
Jul 31, 2026
Sale
Shares
182,980
Price
$199.55
Total Value
$36.51M
Shares Held After
28,697,229
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DEXCOM INC
(DXCM)
FOLETTA MARK G
— Director
Jul 31, 2026
Sale
Shares
2,000
Price
$80.00
Total Value
$160.00K
Shares Held After
50,852
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Butterfly Network, Inc.
(BFLY)
Carlson Megan
— CAO and SVP, Finance
Jul 31, 2026
Sale
Shares
68,852
Price
$7.86
Total Value
$541.38K
Shares Held After
425,889
% of Holdings
13.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IQVIA HOLDINGS INC.
(IQV)
Patel Bhavik
— President, MedTech and Consumer Health Power of Attorney
Jul 31, 2026
Sale
Shares
1,855
Price
$235.27
Total Value
$436.43K
Shares Held After
1,348
% of Holdings
57.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BillionToOne, Inc.
(BLLN)
Sakakibara Shan Riku
— Chief Product Officer
Jul 31, 2026
Sale
Shares
4,000
Price
$140.21
Total Value
$560.84K
Shares Held After
200,000
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
Juvenal Tobin W
— Chief Commercial Officer
Jul 31, 2026
Sale
Shares
1,891
Price
$30.26
Total Value
$57.23K
Shares Held After
80,725
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
Juvenal Tobin W
— Chief Commercial Officer
Jul 31, 2026
Sale
Shares
7,270
Price
$29.58
Total Value
$215.04K
Shares Held After
82,616
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
Juvenal Tobin W
— Chief Commercial Officer
Jul 31, 2026
Sale
Shares
8,149
Price
$28.84
Total Value
$235.03K
Shares Held After
89,886
% of Holdings
8.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Jul 31, 2026
Sale
Shares
1,690
Price
$30.15
Total Value
$50.96K
Shares Held After
30,606
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Jul 31, 2026
Sale
Shares
1,983
Price
$30.15
Total Value
$59.79K
Shares Held After
36,013
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Jul 31, 2026
Sale
Shares
6,480
Price
$30.15
Total Value
$195.38K
Shares Held After
21,479
% of Holdings
23.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
2,293
Price
$119.41
Total Value
$273.81K
Shares Held After
61,441
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
326
Price
$121.69
Total Value
$39.67K
Shares Held After
63,734
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
85
Price
$122.19
Total Value
$10.39K
Shares Held After
64,060
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
1,642
Price
$119.38
Total Value
$196.02K
Shares Held After
64,145
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
1,643
Price
$119.51
Total Value
$196.35K
Shares Held After
65,787
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
2,864
Price
$119.40
Total Value
$341.96K
Shares Held After
67,430
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
4,695
Price
$119.39
Total Value
$560.54K
Shares Held After
70,294
% of Holdings
6.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
6,171
Price
$119.43
Total Value
$737.00K
Shares Held After
74,989
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
2,187
Price
$119.47
Total Value
$261.28K
Shares Held After
81,160
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
5,332
Price
$119.42
Total Value
$636.75K
Shares Held After
83,347
% of Holdings
6.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
Mayes Patrick A
— EVP&Chief Scientific Officer
Jul 31, 2026
Sale
Shares
14,661
Price
$119.46
Total Value
$1.75M
Shares Held After
88,679
% of Holdings
14.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INCYTE CORP
(INCY)
CAGNONI PABLO J
— President, Global Head of R&D
Jul 31, 2026
Sale
Shares
15,888
Price
$119.70
Total Value
$1.90M
Shares Held After
215,444
% of Holdings
6.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anteris Technologies Global Corp.
(AVR)
L1 Capital Pty Ltd
— 10% Owner
Jul 31, 2026
Sale
Shares
48,711
Price
$8.15
Total Value
$396.99K
Shares Held After
6,584,603
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KESTRA MEDICAL TECHNOLOGIES, LTD.
(KMTS)
Umberger Traci S
— Director
Jul 31, 2026
Sale
Shares
8,752
Price
$22.60
Total Value
$197.84K
Shares Held After
206,995
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KESTRA MEDICAL TECHNOLOGIES, LTD.
(KMTS)
Webster Brian Daniel
— Director
Jul 31, 2026
Sale
Shares
8,948
Price
$22.60
Total Value
$202.26K
Shares Held After
540,132
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KESTRA MEDICAL TECHNOLOGIES, LTD.
(KMTS)
Mahboob Vaseem
— Chief Financial Officer
Jul 31, 2026
Sale
Shares
8,817
Price
$22.61
Total Value
$199.34K
Shares Held After
99,282
% of Holdings
8.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KESTRA MEDICAL TECHNOLOGIES, LTD.
(KMTS)
Ford Alfred J Jr
— Chief Commercial Officer
Jul 31, 2026
Sale
Shares
8,681
Price
$22.61
Total Value
$196.28K
Shares Held After
118,854
% of Holdings
6.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KESTRA MEDICAL TECHNOLOGIES, LTD.
(KMTS)
Moran Timothy P.
— Chief Business Officer
Jul 31, 2026
Sale
Shares
8,759
Price
$22.61
Total Value
$198.00K
Shares Held After
68,725
% of Holdings
11.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Butterfly Network, Inc.
(BFLY)
ROBBINS LARRY
— Director
Jul 31, 2026
Sale
Shares
1,720,129
Price
$7.39
Total Value
$12.72M
Shares Held After
12,614,926
% of Holdings
12.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NextCure, Inc.
(NXTC)
ADAR1 Capital Management, LLC
— 10% Owner
Jul 31, 2026
Purchase
Shares
8,003
Price
$4.80
Total Value
$38.41K
Shares Held After
722,419
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NextCure, Inc.
(NXTC)
ADAR1 Capital Management, LLC
— 10% Owner
Jul 31, 2026
Purchase
Shares
25,000
Price
$4.98
Total Value
$124.54K
Shares Held After
714,416
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NextCure, Inc.
(NXTC)
ADAR1 Capital Management, LLC
— 10% Owner
Jul 31, 2026
Purchase
Shares
3,300
Price
$4.98
Total Value
$16.42K
Shares Held After
689,416
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SHOULDER INNOVATIONS, INC.
(SI)
Gilde Healthcare Holding B.V.
— 10% Owner
Jul 31, 2026
Sale
Shares
20,034
Price
$22.73
Total Value
$455.37K
Shares Held After
2,332,203
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Entrada Therapeutics, Inc.
(TRDA)
5AM Ventures V, L.P.
— 10% Owner
Jul 31, 2026
Sale
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Entrada Therapeutics, Inc.
(TRDA)
PARMAR KUSH
— Director
Jul 31, 2026
Sale
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
WEN LEANA
— Director
Jul 31, 2026
Sale
Shares
525
Price
$167.63
Total Value
$88.01K
Shares Held After
21,092
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BOSTON SCIENTIFIC CORP
(BSX)
LUDWIG EDWARD J
— Director
Jul 31, 2026
Purchase
Shares
5,000
Price
$45.48
Total Value
$227.40K
Shares Held After
30,359
% of Holdings
16.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
238
Price
$522.88
Total Value
$124.44K
Shares Held After
324,443
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
282
Price
$521.52
Total Value
$147.07K
Shares Held After
324,681
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
1,517
Price
$520.80
Total Value
$790.06K
Shares Held After
324,963
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
2,627
Price
$520.12
Total Value
$1.37M
Shares Held After
326,480
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
1,266
Price
$519.06
Total Value
$657.12K
Shares Held After
329,107
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
1,215
Price
$518.00
Total Value
$629.37K
Shares Held After
330,373
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
1,133
Price
$516.94
Total Value
$585.70K
Shares Held After
331,588
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
857
Price
$515.84
Total Value
$442.07K
Shares Held After
332,721
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jul 31, 2026
Sale
Shares
365
Price
$514.82
Total Value
$187.91K
Shares Held After
333,578
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ProQR Therapeutics N.V.
(PRQR)
de Boer Daniel Anton
— Director
Jul 31, 2026
Purchase
Shares
200,000
Price
$1.77
Total Value
$353.96K
Shares Held After
500,000
% of Holdings
40.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CHEMED CORP
(CHE)
GRACE PATRICK P
— Director
Jul 31, 2026
Sale
Shares
190
Price
$532.00
Total Value
$101.08K
Shares Held After
3,533
% of Holdings
5.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Next →
Showing 1–50 of 1439 transactions (page 1 of 29)
Version: v26.7.3